Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin Dosing”

63 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 63 results

Not applicableStudy completedNCT02438189
What this trial is testing

Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms

Who this might be right for
Type 1 Diabetes
Jaeb Center for Health Research 33
Post-approval studies (Phase 4)UnknownNCT02361489
What this trial is testing

Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go ® in Patients With Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care Offices

Who this might be right for
Diabetes Type II
Valeritas, Inc. 90
Not applicableStudy completedNCT01377155
What this trial is testing

A Comparison of Two Initial Dosing Formulas

Who this might be right for
Diabetes Mellitus, Type 2
Diabetes Care Center 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT06600776
What this trial is testing

Mealtime or Post-meal Dosing of URLi in Medtronic 780G Hybrid Closed Loop System

Who this might be right for
Type 1 Diabetes (T1D)
Tel-Aviv Sourasky Medical Center 50
Not applicableUnknownNCT05924932
What this trial is testing

Effect of HCL Insulin Delivery System on Glycemic Control in Patients With T1D

Who this might be right for
Diabetes Mellitus, Type 1
Masaryk Hospital Usti nad Labem 120
Large-scale testing (Phase 3)Study completedNCT01006291
What this trial is testing

Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 687
Testing effectiveness (Phase 2)Study completedNCT01697618
What this trial is testing

Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 13
Not applicableEnded earlyNCT00869414
What this trial is testing

Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes

Who this might be right for
Type 1 DiabetesHypoglycemia
Johns Hopkins University 16
Not applicableStudy completedNCT05514080
What this trial is testing

Evaluate Eli Lilly's Insulin Dosing Algorithm to Control Glycemia in Insulin-treated Adults With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
McGill University 10
Early research (Phase 1)Study completedNCT01444677
What this trial is testing

Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers

Who this might be right for
Metabolic SyndromeObesity
Yungjin Pharm. Co., Ltd. 40
Not applicableEnded earlyNCT00263445
What this trial is testing

Constructing an Insulin-Like Growth Factor-based Prediction Model

Who this might be right for
Growth Hormone DeficiencyIdiopathic Short StatureSmall for Gestational Age
University of California, Los Angeles 30
Not applicableWithdrawnNCT02835183
What this trial is testing

Evaluation of iDECIDE: A Smartphone App for Insulin Dosing Accounting for Alcohol and Exercise

Who this might be right for
Type 1 Diabetes
Arizona State University
Early research (Phase 1)Study completedNCT01349855
What this trial is testing

Repeated Dosing Study With a New Insulin Glargine Formulation and Lantus® in Patients With Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
Sanofi 30
Not applicableWithdrawnNCT04667182
What this trial is testing

Glucose Control in Participants With Type 1 and Type 2 Diabetes

Who this might be right for
Type 1 DiabetesType 2 Diabetes
Eli Lilly and Company
Post-approval studies (Phase 4)Not Yet RecruitingNCT07747402
What this trial is testing

Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Xi'an International Medical Center Hospital 462
Not applicableStudy completedNCT02914730
What this trial is testing

Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections

Who this might be right for
DiabetesMedication AdherenceTechnology+1 more
Joslin Diabetes Center 75
Large-scale testing (Phase 3)Study completedNCT01880736
What this trial is testing

A Trial Investigating the Efficacy and Safety of Flexible vs. Fixed Dosing and Simple vs. Stepwise Titration With Once Daily (OD) Insulin Degludec in Inadequately Treated Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 458
Large-scale testing (Phase 3)Study completedNCT00391209
What this trial is testing

Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 379
Post-approval studies (Phase 4)Study completedNCT00552370
What this trial is testing

Glycemic Optimization Treatment Study

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 5,062
Testing effectiveness (Phase 2)Study completedNCT02714972
What this trial is testing

Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents

Who this might be right for
Type 1 DiabetesHypoglycemiaHyperglycemia+1 more
Jaeb Center for Health Research 35
Next Page